Showing 771-780 of 2571 results for "".
Cerebral Vasoconstriction and Vasospastic Angina Secondary to Pheochromocytoma
https://practicalneurology.com/diseases-diagnoses/headache-pain/cerebral-vasoconstriction-and-vasospastic-angina-secondary-to-pheochromocytoma/31979/This is the first reported case of pheochromocytoma associated with both RCVS and vasospastic angina in the same patient.Posttraumatic Headache Associated with Mild Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/posttraumatic-headache-associated-with-mild-traumatic-brain-injury/31993/Diagnosis and treatment of posttraumatic headache associated with mTBI, including onset, headache characteristics, and persistenceMedical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-what-do-animal-models-ofalzheimers-disease-tell-us/31560/Understanding pathologic mechanisms provides test beds for finding treatments.An Update on Nutraceuticals for Migraine Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-nutraceuticals-for-migraine-management/32132/Many people with migraine use integrative modalities, including nutraceutical supplements, along with mainstream medicine for disease control.The Central Vein Sign
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-central-vein-sign/31627/Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?Clinical Approach to Neurocognitive Symptoms: A Practical Framework for Primary Care, General Neurology, and Psychiatry
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-approach-to-neurocognitive-symptoms-a-practical-framework-for-primary-care-general-neurology-and-psychiatry/67049/With disease-modifying therapies now available for early Alzheimer disease, a structured approach for evaluating cognitive complaints can help clinicians identify appropriate candidates for biomarker testing, specialist referral, and treatment.Selection and Interpretation of Biomarker Tests for Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/selection-and-interpretation-of-biomarker-tests-for-alzheimer-disease/36191/Diagnostic tests for Alzheimer disease can help guide clinical management, but results must be interpreted carefully.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.Evaluating Heterogeneous Treatment Effects in Pursuit of Personalized Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/evaluating-heterogeneous-treatment-effects-in-pursuit-of-personalized-multiple-sclerosis-care/33141/Heterogeneous treatment effect methodologies can be used to enhance individualized care for people with multiple sclerosis.